This is the authors' abstract. We don't add key points for this paper.
Summary Splenectomy is an effective treatment for immune thrombocytopenia (ITP). The effect of COVID‐19 vaccination on splenectomized patients with ITP during the COVID‐19 pandemic has not been reported. Therefore, this study aimed to investigate the effect of COVID‐19 vaccination on clinical outcomes in these patients. This was a longitudinal study of splenectomized patients with ITP. A total of 191 splenectomized patients were included in this study. After a median follow‐up of 114 months, 146 (76.4%) patients had a sustained response to splenectomy. During COVID‐19 infection, vaccinated patients showed a lower risk of severe infections (odds ratio [OR], 0.13; 95% confidence interval [CI]: 0.05–0.36; p < 0.001), hospitalization (OR, 0.13; 95% CI, 0.04–0.48; p = 0.002), and ITP exacerbation (OR, 0.16; 95% CI, 0.04–0.67; p = 0.012). These findings indicate that COVID‐19 vaccination plays a protective role in splenectomized patients with ITP.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: